FDA Inspection
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. (FDF Site)Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. (FDF Site) – FDA Inspection, Apr 3, 2018
Record Details
This FDA Inspection record concerns Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. (FDF Site), with an inspection on April 3, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- April 3, 2018
- Product Type
- Drugs
- People
- Darren S. Brown (FDA Associated Person)
- Djamila Harouaka (FDA Associated Person)
- Ruo H. Xu (Issuing Officer)
View Company Profile
ID · d3773b17-cb38-4afe-b580-e28b4076894a
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1048084
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. (FDF Site)
4| Date | Classification | Office | Project area |
|---|---|---|---|
| December 15, 2025 | Not classified | Office of Inspections and Investigations | |
| November 10, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 22, 2019 | Not classified | Office of Inspections and Investigations | |
| May 12, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. (FDF Site)
- FDA Inspection 1295788 - 2025-12-15
- FDA Inspection 1224895 - 2023-11-10
- FDA Inspection 1082504 - 2019-02-22
- FDA Inspection 937313 - 2015-05-12
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.